
Join to View Full Profile
423 E 23rd St9th FloorNew York, NY 10010
Phone+1 212-686-7500
Dr. Griffin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a physician-scientist continuing my clinical and scientific training at the NYU Langone Medical Center through the Clinical Investigator Track of the internal medicine residency. I completed my doctoral research through the Graduate School of Arts and Sciences in the Califano Laboratory of Systems Biology where I leveraged tumor transcriptomic data and novel computational algorithms to identify and target transcriptional regulatory proteins (i.e., Master Regulators) which coordinate phenotypes of resistance to targeted therapy and immune checkpoint inhibitors in thoracic malignancies. I completed my medical doctorate at the Vagelos College of Physicians and Surgeons at New York Presbyterian Hospital. My career goal is to combine clinical oncology and computational biology to advance personalized cancer diagnosis and treatment strategies as an independent physician-scientist.
Education & Training
- NYU Grossman School of MedicineResidency, Internal Medicine, 2024 - 2027
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2024
Publications & Presentations
PubMed
- Genome-wide studies define new genetic mechanisms of IgA vasculitis.Lili Liu, Li Zhu, Sara Monteiro-Martins, Aaron Griffin, Lukas J Vlahos
Medrxiv. 2024-10-11 - 3 citationsNetwork-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis.George Rosenberger, Wenxue Li, Mikko Turunen, Jing He, Prem S Subramaniam
Nature Communications. 2024-05-09 - 63 citationsGenomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.Arvind Ravi, Matthew D Hellmann, Monica B Arniella, Mark Holton, Samuel S Freeman
Nature Genetics. 2023-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: